Defence Therapeutics Inc.
DTC
Rank in Stocks
#29259
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Share Price
$0.27889602
Last synced: 2026-10-19
Market Cap
$21.14M
Change (1 day)
11.76%
Change (1 year)
-52.35%
Country
CA
Trade Defence Therapeutics Inc. (DTC)
Category
Healthcare
Stock split history for Defence Therapeutics Inc. (DTC)
Defence Therapeutics Inc. stock (symbol: DTC) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One DTC share bought prior to Oct 20, 2026 would equal to 0 DTC shares today.
The most recent stock split occurred on Oct 20, 2026.
One DTC share bought prior to Oct 20, 2026 would equal to 0 DTC shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
